Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer grou…
What to know about ELV
Elevance Health, Inc. is a large Healthcare company with a mixed financial profile. It scores well on valuation and size, but profitability is worth keeping an eye on.
Should you consider ELV?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Elevance Health, Inc. is a large-cap Healthcare company with a mixed overall financial profile — it is in the lower half of its Healthcare peers (41 of 59).
-
Profit margins are thin compared to most S&P 500 peers — the company keeps less of each dollar it earns than the average. Watch for signs of margin improvement.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
There is a small dividend (0.02%), but income-focused investors will likely find better yields elsewhere in the market.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
There are several areas of concern. This may suit investors with a higher risk tolerance or a specific contrarian view on the Healthcare sector.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how ELV compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 16.47 | Top 25% |
| Forward P/E | 13.28 | Above avg |
| PEG Ratio | 1.46 | Above avg |
| Price to Sales | 0.42 | Top 25% |
| Price to Book | 1.92 | Above avg |
| EV/EBITDA | 9.52 | Top 25% |
| Earnings Yield | 6.07% | Top 25% |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 25.89% | Below avg |
| Operating Margin | 5.30% | Below avg |
| Net Profit Margin | 2.62% | Below avg |
| Return on Equity | 12.09% | Average |
| Return on Invested Capital | 3.98% | Average |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 2.60% | Below avg |
| Revenue Growth (3Y CAGR) | 8.34% | Above avg |
| EPS Growth (YoY) | -16.80% | Below avg |
| Free Cash Flow Growth | -30.27% | Below avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.48 | Above avg |
| Debt to Equity | 0.72 | Above avg |
| Interest Coverage | 5.79 | Average |
| Altman Z-Score | — | N/A |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 1.73% | Average |
| Payout Ratio | 29.03% | Above avg |
| Dividend Growth (5Y) | -5.31% | Above avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 7.65% | Top 25% |
| OCF to Sales | 3.79% | Below avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.68 | Above avg |
| Volatility (30-Day) | 29.60% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 3.40% | Above avg |
| Avg. Analyst Rating | 1.82 | Above avg |
| Target Upside % | 7.03% | Average |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 84.37B | Above avg |
How does ELV compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to ELV — based on their financial profile.